Acotiamide PCD Pharma Franchise Company
Cafoli Lifecare invites distributors, stockists and pharma professionals to take up an Acotiamide PCD pharma franchise across India. Our Acotiamide range comprises 2 tablet formulations marketed under the Actohub brand, manufactured in WHO-GMP certified facilities and supplied with complete quality documentation and monopoly rights.
What is Acotiamide?
Acotiamide is a first-in-class gastric prokinetic agent developed specifically for functional dyspepsia. It works through a dual mechanism — it antagonises inhibitory muscarinic M1 and M2 autoreceptors on enteric cholinergic nerve endings and inhibits acetylcholinesterase, so more acetylcholine is available at the neuromuscular junction of the stomach. The result is improved gastric accommodation and accelerated gastric emptying, without the dopamine-receptor activity seen with older prokinetics. See PubChem: Acotiamide for its chemical and pharmacological profile.
Acotiamide Products Available for Franchise
| Brand Name | Composition | Packing | MRP |
|---|
| Actohub 100 Tablet |
Acotiamide (100mg) Tablet |
Alu Alu, 10*10 |
₹233/- |
| Actohub 300 ER Tablet |
Acotiamide (300mg) Tablet |
Alu Alu, 10*1*10 |
₹420/- |
Therapeutic Applications of Acotiamide
Acotiamide is indicated for the treatment of functional dyspepsia, particularly the postprandial distress syndrome subtype, where patients present with early satiety, postprandial fullness and upper abdominal bloating in the absence of structural disease. Because it targets impaired gastric accommodation and delayed emptying rather than acid secretion, it is frequently prescribed where proton pump inhibitors alone have not relieved symptoms.
The molecule is prescribed chiefly by gastroenterologists, general physicians and consulting internists.
Why Acotiamide is a High-Potential Molecule for Distributors
Functional dyspepsia is one of the most common presentations in Indian general practice, yet for years the only options were PPIs and conventional prokinetics such as domperidone and levosulpiride — the latter carrying well-known extrapyramidal and prolactin-related concerns with prolonged use. Acotiamide is comparatively new to the Indian market and gives prescribers a non-dopaminergic alternative suited to longer courses, which is exactly the profile that supports repeat business. Fewer companies have built an Acotiamide range so far, so a distributor entering now faces limited brand competition at the chemist counter while demand is still expanding.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers monopoly distribution rights on a district or territory basis, WHO-GMP certified manufacturing and DCGI-approved products. Franchise partners receive full promotional inputs including visual aids, product cards, samples, MR bags and prescription pads, backed by transparent pricing and reliable dispatch. Over 1000+ partners across India already distribute with us.
References
- PubChem Compound Summary – Acotiamide
- PubMed – Acotiamide in functional dyspepsia
Our formulations of Acotiamide find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: